Evidence map›Paper›PMID 37122629›Full record

ArticleInternational journal of cardiology. Heart & vasculature2023

Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications.

Baravan Al-Kassou, Hasanin Al-Shaikh, Adem Aksoy, Jasmin Shamekhi, Andreas Zietzer, Atsushi Sugiura, Verena Veulemans, Matti Adam, Eberhard Grube, Farhad Bakhtiary and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Recent highlights from theInternational journal of cardiology. Heart & vasculature · 2025
    Article
  2. Transcatheter aortic valve implantation: latest evidence, gaps in knowledge, and future directions.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Baravan Al-KassouHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Hasanin Al-ShaikhHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Adem AksoyHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Jasmin ShamekhiHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Andreas ZietzerHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Atsushi SugiuraHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Verena VeulemansDivision of Cardiology, University Hospital of Duesseldorf, Germany.
Matti AdamDepartment of Cardiology, Heart Center, University of Cologne, Cologne, Germany.
Eberhard GrubeHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Farhad BakhtiaryHeart Center, Department of Cardiac Surgery, University Hospital Bonn, Bonn, Germany.
Sebastian ZimmerHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Malte KelmCARID, Cardiovascular Research Institute Duesseldorf, Germany.
Stephan BaldusDepartment of Cardiology, Heart Center, University of Cologne, Cologne, Germany.
Georg NickenigHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Alexander SedaghatHeart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
University Hospital Bonn · DEUniversity of Cologne · DEDüsseldorf University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vascular injury and bleeding complications remain frequent after transcatheter aortic valve replacement (TAVR). Whether the access-site of preprocedural coronary angiography (CAG) affects TAVR-related complications is not known. The aim of this study was to evaluate the impact of transradial (TRA) versus transfemoral access (TFA) for preprocedural CAG on outcomes in patients undergoing subsequent TAVR. Methods: The study cohort included 1002 patients undergoing transfemoral TAVR, of whom 39.4% (395/1002) had undergone radial and 60.6% (607/1002) femoral access for pre-TAVR CAG. The primary endpoint was a composite of 30-day mortality and major vascular complications after TAVR. Key secondary endpoints included VARC-3-defined complications. Results: The primary endpoint occurred less frequently in patients with prior TRA (3.3%) as compared to patients with prior TFA (6.3%, p = 0.04), which was mainly driven by significantly lower rates of major vascular complications (0.8% vs 2.5%, p = 0.05). Moreover, incidences of periprocedural access-related vascular injury and unplanned endovascular interventions were lower in TRA patients (13.2% vs 18.0%, p = 0.05). The rate of major bleeding tended to be lower in the TRA (1.5%) as compared to the TFA group (3.5%) but was not significantly different (p = 0.07). Moreover, the rate of life-threatening bleeding was comparable between both groups (0.5% vs 0.8%, p = 0.71). Conclusion: Transradial access for preprocedural CAG was associated with significantly lower rates of vascular complications following subsequent TAVR as compared to transfemoral access. However, despite the tendency to lower major bleedings with transradial access, no significant association was detectable between the access-site of coronary angiography and TAVR-related bleeding complications.

Indexed as

Coronary angiographyTAVRVascular access wayVascular complication

Identifiers

PMID37122629
PMCPMC10130599
OpenAlexW4365455913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.